BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2324966)

  • 1. Dissolution testing of norethindrone:ethinyl estradiol, norethindrone:mestranol, and norethindrone acetate:ethinyl estradiol combination tablets.
    Nguyen HT; Shiu GK; Worsley WN; Skelly JP
    J Pharm Sci; 1990 Feb; 79(2):163-7. PubMed ID: 2324966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the U.S.P. dissolution method for the analysis of norethindrone and ethinyl estradiol tablets.
    Dorantes A; Stavchansky S
    J Pharm Sci; 1994 Mar; 83(3):379-81. PubMed ID: 8207685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of ethynodiol diacetate and ethinyl estradiol/mestranol in oral contraceptive tablets by high-performance liquid chromatography.
    Carignan G; Lodge BA; Skakum W
    J Pharm Sci; 1982 Feb; 71(2):264-6. PubMed ID: 7062257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Simultaneous determination using gas chromatography of mestranol and norethisterone in estrogen-progestins combination for oral use].
    Moretti G; Cavina G; Chiappetta G; Fattori I; Petrella M; Pompi V
    Boll Chim Farm; 1977 Aug; 116(8):463-72. PubMed ID: 921851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norethindrone acetate (NA) and ethinyl estradiol (EE) related oxidative transformation products in stability samples of formulated drug product: synthesis of authentic references.
    Ekhato IV; Hurley T; Lovdahl M; Revitte TJ; Guo L; Huang Y; Clipper S; Colson C
    Steroids; 2002 Mar; 67(3-4):165-74. PubMed ID: 11856540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of three bioequivalent norethindrone/mestranol-50 micrograms and three norethindrone/ethinyl estradiol-35 micrograms OC formulations: are "low-dose" pills really lower?
    Brody SA; Turkes A; Goldzieher JW
    Contraception; 1989 Sep; 40(3):269-84. PubMed ID: 2766722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple high-performance liquid chromatographic assay for norethindrone--mestranol in combination tablets.
    Sundaresan GM; Goehl TJ; Prasad VK
    J Pharm Sci; 1981 Jun; 70(6):702-4. PubMed ID: 7252827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatographic patterns of urinary ethynyl estrogen metabolites in various populations.
    Williams MC; Goldzieher JW
    Steroids; 1980 Sep; 36(3):255-82. PubMed ID: 7434400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of 9-alpha,11-xi-tritiated 17-alpha-ethynylestradiol, mestranol, estradiol-alpha-17-beta, and norethindrone.
    Rao PN
    Steroids; 1971 Aug; 18(2):219-29. PubMed ID: 5126820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications.
    Goldzieher JW
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):318-22. PubMed ID: 2196804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated stability-indicating high-performance liquid chromatographic assay for ethinyl estradiol and (levo)norgestrel tablets.
    Reif VD; Eickhoff WM; Jackman JK; DeAngelis NJ
    Pharm Res; 1987 Feb; 4(1):54-8. PubMed ID: 3150042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutual modification of glucose-stimulated serum insulin responses in female rhesus monkeys by ethinyl estradiol and nortestosterone derivatives.
    Beck P; Venable RL; Hoff DL
    J Clin Endocrinol; 1975; 41(1):44-53. PubMed ID: 12334063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas chromatography of oral progestagens and estrogens.
    Prous JR; Sussmann AR
    Med Actual; 1968; 4(2):56-7. PubMed ID: 12334354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proposed method for the determination of the components of an oral contraceptive mixture (norethisterone acetate and ethinyl estradiol).
    Belal S; Elnenaey EA
    Pharmazie; 1977 Feb; 32(2):125. PubMed ID: 859906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.